Video

Penn Surgeons Perform World’s First En Bloc Resection of Rare Chordoma Tumor

See how Penn Medicine surgeons removed a rare cervical chordoma en-bloc, using Trans Oral Robotic Surgery (TORS).

Video

3D Modeling for Reconstructive Surgery | Virtual Surgical Planning (VSP) at Penn Medicine

Learn how 3D mapping and printing relate to reconstructive surgery at Penn Medicine, where Virtual Surgical Planning (VSP) technology is pivotal to the pre-surgical process.

Video

TORS for Head & Neck Cancer Care: Innovative, Minimally-Invasive Surgery Technique Invented at Penn

TransOral Robotic Surgery (TORS) is a minimally-invasive, robot-assisted surgical technique to remove tumors of the mouth and throat that are difficult to reach through traditional surgery.

Video

Penn Otorhinolaryngology: Innovative Expert Care for Complex Cases

At Penn Otorhinolaryngology – Head and Neck Surgery, we pride ourselves on being able to provide complex care for the most challenging and rare cases.

Video

Overview of the Diagnosis and Early Management of Thyroid Cancer: Early signs of aggressive disease

Caroline Kim, MD, examines the warnings signs for aggressive and recurrent disease in patients lacking structurally identifiable disease after initial therapy.

Video

The Management of the Medullary Thyroid Cancer Patient

Caroline S. Kim, MD, reviews the pathology and management of medullary thyroid cancer.

Video

Surgery for Recurrent Thyroid Cancer: Considerations and Limitations

Surgeon Ara A. Chalian, MD, FACS, reviews the procedures and indications for surgery in the patient with recurrent thyroid cancer.

Video

Approved: Sorafenib and Lenvatinib for the Treatment of Progressive, RAI-­Refractory DTC

Marcia Brose, MD, discusses the treatment of radioiodine-­refractory differentiated thyroid cancer with the kinase inhibitors sorafenib and lenvatinib.

Video

Surgery for Advanced and Recurrent Differentiated Thyroid Cancer

Ara Chalian, MD, discusses the role and challenges of surgery in the treatment of advanced and recurrent thyroid cancer.

Advance in Understanding Actin Sheds Light on Cell Function

Awards and Accolades: April 2020

Philadelphia Eagles Owner Jeffrey Lurie Gives $1 Million to Penn Medicine Research to Fight COVID-19

PARP Inhibitor Drugs Can be “Tuned” for Better Killing of Tumor Cells

Philadelphia 76ers All-Star Joel Embiid, 76ers Managing Partner Josh Harris, and Co-Managing Partner David Blitzer Join Forces to Provide $1.3 Million to Penn Medicine for Critical Support of Health Care Workers Fighting COVID-19

Penn Launches Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19